Cancer treatment with a cell-based immunotherapy causes mild cognitive impairment, a Stanford Medicine team found. They also identified compounds that could treat it.

A study of more than 100 patients found that immunotherapy can cure a rare type of cancer in various tumor sites without ...

Researchers have developed an innovative dual-receptor T-cell therapy that promises safer and more effective cancer ...

A new study has identified a specific mode of fat uptake by immune cells within tumors that serves as a metabolic checkpoint against anti-cancer immune responses.

Repertoire will obtain an upfront payment of $35m from Genentech, with the potential for up to $730m in additional milestones ...

Repertoire’s platform is designed to map the immune synapse, offering a comprehensive overview of ... Oxford BioTherapeutics to discover new antibody-based therapeutics for cancer. Roche also ...

to discover and develop innovative T cell-targeted immune medicines to treat an autoimmune disease. Repertoire will use its Decode platform, which maps the immune synapse, to discover novel ...

By Carly Thomas Associate Editor Teddi Mellencamp is sharing a positive health update after learning she had multiple tumors and then undergoing emergency brain surgery earlier this year.

Repertoire is built around a technology dubbed Decode that’s designed to identify the components of the “immune synapse,” a type of junction ... Repertoire uses that information to uncover drugs for ...

Cambridge, USA-based biotech Repertoire Immune Medicines today ... maps the entire immune synapse in patients and thereby enables development of transformative T cell-targeted medicines for autoimmune ...